Send Inquiry

Request To Call Back

Drug Eluting Coronary Stents

Name: Drug Eluting Coronary Stents
Brand: Advin Health Care
Price: 200 USD
Availability: InStock

Price 200 USD ($)/ Piece

Get a Price/Quote

MOQ : 1 Piece

Drug Eluting Coronary Stents Specification

Accuracy
High Precision in Placement

Features
Coated with anti-proliferative drugs, biocompatible polymer, radiopaque markers, flexible design

Usage Type
Single Use

Function
Maintains vessel patency and releases drug to prevent restenosis

Instruments Type
Interventional Cardiology Device

Measurement Range
Stent diameters 2.5 - 4.0 mm; lengths 8 - 38 mm

Shelf Life
2 to 3 Years

Storage Instructions
Store at room temperature, away from moisture and sunlight

Equipment Type
Drug Eluting Coronary Stent

Material
Cobalt Chromium Alloy

Condition
New

Technology
Drug Eluting Stent (DES)

Portable
Yes

Wall Mounted
No

Real-Time Operation
Yes

Noise Level
Silent

Operating Type
Manual deployment

Use
Coronary Artery Disease Treatment

Dimension (L*W*H)
Various Sizes Available (Commonly 2.5-4.0 mm diameter, 8-38 mm length)

Weight
Lightweight (Few grams)

Color
Metallic silver

Indication
Intended for use in patients with symptomatic coronary artery disease

Polymer Used
Durable or Bioabsorbable Polymer Coating

MRI Compatibility
Conditional (check specific product guidelines)

Compatibility
Compatible with 0.014 inch guidewire, standard balloon catheters

Radiopacity
Enhanced via radiopaque markers for visibility under fluoroscopy

Delivery System
Pre-mounted on balloon catheter

Surface Finish
Ultra-smooth to minimize vessel trauma

Flexibility
High for easier navigation in tortuous vessels

Expansion Method
Balloon expandable

Sterilization
Ethylene Oxide Sterilized

Drug Coating
Sirolimus/Everolimus/Paclitaxel (drug type varies as per product)

Thrombogenicity
Low (anti-thrombotic coating)

About Drug Eluting Coronary Stents

Advin Health Care offers Drug Eluting Coronary Stents (DES) designed to meet international quality standards. These advanced stents are coated with therapeutic drugs that are gradually released to prevent restenosis, ensuring long-term vessel patency and improved clinical outcomes in coronary artery disease treatment.

Key Features

Controlled drug release to reduce restenosis risk
Advanced stent design for optimal vessel support
Excellent flexibility and deliverability in complex lesions
Uniform drug coating for consistent performance
Biocompatible materials to enhance patient safety

Specifications

Type: Drug Eluting Coronary Stent (DES)
Material: Cobalt Chromium / Stainless Steel
Coating: Drug-eluting polymer coating
Delivery System: Balloon-expandable system
Sterilization: EO Sterilized
Usage: Single-use
Application: Treatment of coronary artery disease (CAD)

Certifications
CE, ISO 13485, and ISO 9001 certified

Product Keywords
Drug Eluting Stent, Coronary Stent, DES Stent, Cardiac Stent, Anti-Restenosis Stent, Angioplasty Stent

DES

, , , , ,

Stent liberador de frmacos, stent coronario, stent DES, stent cardaco, stent antirreestenosis, stent de angioplastia

Stent lution de mdicament, stent coronaire, stent DES, stent cardiaque, stent anti-restnose, stent d'angioplastie

Superior Drug Delivery for Reduced Restenosis

Our stents employ innovative drug coatings like Sirolimus, Everolimus, or Paclitaxel, delivered through a polymer matrix. This technology targets local vascular tissue, minimizing cell overgrowth and restenosis. As the drug is steadily released, vessel patency is maintained over extended periods, providing effective, long-term results for patients with coronary artery disease.

Optimized Design for Precision and Flexibility

Engineered from cobalt chromium alloy and featuring an ultra-smooth surface, the stents offer high flexibility for navigation through tortuous vessels. Enhanced radiopacity from integrated markers ensures clear visibility under fluoroscopy, allowing for confident, accurate placement. The lightweight, portable design further simplifies handling during interventional procedures.

Safe and Compatible with Standard Procedures

The stents are compatible with standard 0.014-inch guidewires and pre-mounted on balloon catheters for single-use deployment. MRI conditional labeling and ethylene oxide sterilization provide added safety. The low-thrombogenic polymer coating and biocompatible materials make these stents a reliable choice for interventional cardiologists.

FAQ's of Drug Eluting Coronary Stents:

Q: How does a drug eluting coronary stent work in treating coronary artery disease?

A: A drug eluting coronary stent is placed inside a narrowed artery using a balloon catheter. After deployment, it maintains vessel patency while slowly releasing anti-proliferative drugs (such as Sirolimus, Everolimus, or Paclitaxel) to prevent restenosis by inhibiting excessive tissue growth within the arterial wall.

Q: What steps are followed during the placement of these stents?

A: The stent, pre-mounted on a balloon catheter and compatible with a 0.014-inch guidewire, is guided to the site of blockage. Under fluoroscopy, radiopaque markers help accurately position the stent. The balloon is then inflated to expand the stent, anchoring it within the vessel, after which the catheter is withdrawn.

Q: When should a drug eluting coronary stent be used?

A: These stents are indicated for patients with symptomatic coronary artery disease requiring intervention to restore adequate blood flow. They are particularly recommended when the risk of restenosis or vessel re-narrowing is a concern.

Q: Where should these stents be stored before use?

A: The stents should be stored at room temperature in their original packaging, away from moisture and sunlight, to preserve sterility and ensure optimal performance until their use within the 2-3 year shelf life.

Q: What compatibility features do these stents offer for interventional procedures?

A: These stents are designed for compatibility with standard 0.014-inch guidewires and balloon catheters, making them suitable for routine interventional cardiology procedures. Their balloon-expandable nature and radiopaque markers provide further ease and precision during deployment.

Q: What are the benefits of using drug eluting stents with anti-thrombotic coating?

A: The anti-thrombotic coating significantly reduces the risk of blood clot formation on the stent's surface, while the controlled drug release prevents tissue overgrowth. Together, these mechanisms lower the chances of restenosis and adverse cardiac events after the procedure.

Q: Is this stent suitable for use in patients requiring MRI?

A: The stent is conditionally MRI compatible, but users must refer to specific product guidelines to ensure safe imaging practices for patients who may require MRI scans after stent placement.

Tell us about your requirement